Actively Recruiting
Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk.
Led by UNICANCER · Updated on 2026-02-27
1508
Participants Needed
3
Research Sites
66 weeks
Total Duration
On this page
Sponsors
U
UNICANCER
Lead Sponsor
E
European Union
Collaborating Sponsor
AI-Summary
What this Trial Is About
Breast cancer remains the most common cancer among women and a major cause of death despite advances in screening and treatment. Current screening programs are not personalized and are experiencing declining participation. A promising strategy for breast cancer control would be to implement risk-based prevention and early screening, targeting individuals at high risk of developing breast cancer, in order to improve chances of cure and reduce the need for more intensive treatments. The MyPeBS study was designed to assess whether personalized breast cancer screening (based on an individual's risk of developing breast cancer) is as effective as, or more effective than, current standard screening. Lifestyle interventions involving changes in diet or physical activity, for example, have been shown to be effective in reducing the risk of developing breast cancer, whether low or high. The MyPeBS study evaluates personalized screening but offers limited information on breast cancer prevention. MyPREV is a project that aims to assess the feasibility and impact of a personalized online program on breast cancer risk reduction measures. This program is offered to women at high risk of developing breast cancer as part of the European MyPeBS screening study. The main objective is to evaluate adherence to a personalized, online breast cancer prevention program focused on lifestyle and its acceptance among women at high or very high risk of developing cancer who participated in the MyPeBS study.
CONDITIONS
Official Title
Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female (including those born female or not)
- Aged 40 to 74 years (inclusive)
- Participated or currently participating in the MyPeBS study and met its eligibility criteria
- Able to express non-opposition to participate in the intervention
- Assessed as high (≥1.67% to 5.9%) or very high (≥6%) risk of invasive breast cancer within 5 years in the MyPeBS study
You will not qualify if you...
- Women who developed breast cancer during follow-up in the MyPeBS study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Centre Médical et Dentaire de Lyon MGEN
Lyon, France, 69003
Actively Recruiting
2
Gustave Roussy
Villejuif, France
Not Yet Recruiting
3
AOU Città della Salute e della Scienza - CPO PiedmontSSD Epidemiologia e Screening
Torino, Italy
Not Yet Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here